NICOTINE REPLACEMENT THERAPY - 07/09/11
Résumé |
The Agency for Health Care Policy and Research (AHCPR) Clinical Practice Guideline on Smoking Cessation states that “All physicians should strongly advise every patient who smokes to quit.” Randomized clinical trials have shown that physician advice to quit smoking by itself improves cessation rates by 30%.63 Physicians can further aid smokers by recommending nicotine replacement therapy (NRT) to their patients to aid in their quit attempts.63 NRT has been shown to be efficacious in helping smokers quit. In fact, the data to support the efficacy of NRT are strong enough that the AHCPR recommends the following to physicians: “Patients should be encouraged to use nicotine replacement therapy (patch or gum) for smoking cessation, except in the presence of special circumstances (e.g., cardiovascular disease, pregnancy).” The public health impact of treating smokers is enormous. It has been estimated that 400,000 premature deaths in the United States each year are attributable to cigarette smoking40 and that up to one half of all smokers die prematurely from tobacco-related disease.47 Cigarette smoking has been shown to cause myriad diseases and disorders that cost smokers their health and their lives and that cost society approximately $100 billion annually.9
Cigarettes are to lung cancer what contaminated heroin needles are to HIV and hepatitis; in both cases, the role of the highly addictive drug (nicotine or heroin) is to sustain repetitive use.21 That is, the death and disease caused by cigarette smoking is not primarily due to nicotine, but rather the huge number of carcinogens and other toxins produced by the burning and inhalation of tobacco. With one third to one half of occasional users graduating to maladaptive use and physical dependence, cigarettes are one of the most addictive drugs known.16, 22 The main cause of death from nicotine and heroin dependence is the contaminated drug delivery system (and not the drug itself), therefore, an important treatment modality for tobacco and heroin dependence is to provide a medication with a favorable risk-to-benefit ratio to replace the drug of abuse, that is, oral methadone for heroin or nicotine medications for tobacco. The vast majority of smokers in the United States report that they would like to quit; however, only about 3% of smokers who quit abruptly on their own (cold turkey) remain abstinent for longer than 6 months.32 It has been repeatedly shown that NRT is an effective aid in the treatment of tobacco abstinence.63 This article summarizes the scientific rationale for nicotine replacement medication, describes the clinical features of each of the currently available medications, and offers recommendations as to how nicotine replacement medications might be used in the future to treat tobacco dependence.
Le texte complet de cet article est disponible en PDF.Plan
| Address reprint requests to Reginald V. Fant, PhD, Pinney Associates, 4800 Montgomery Lane, Suite 1000, Bethesda, Maryland 20814, e-mail: rfant@pinneyassociates.com This paper was written, in part, with financial support from SmithKline Beecham Consumer Healthcare. |
Vol 26 - N° 3
P. 633-652 - septembre 1999 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
